MEIP
MEI Pharma Inc
Price:  
3.56 
USD
Volume:  
32,825.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MEIP WACC - Weighted Average Cost of Capital

The WACC of MEI Pharma Inc (MEIP) is 5.9%.

The Cost of Equity of MEI Pharma Inc (MEIP) is 8.20%.
The Cost of Debt of MEI Pharma Inc (MEIP) is 5.00%.

Range Selected
Cost of equity 6.90% - 9.50% 8.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 6.6% 5.9%
WACC

MEIP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 6.6%
Selected WACC 5.9%